Population Pharmacokinetics and Pharmacogenetics Analyses of Dasatinib in Chinese Patients with Chronic Myeloid Leukemia
ConclusionsThis study ’s findings suggested that low-dose dasatinib would be better suited for Chinese patients, and the dosage can be appropriately reduced according to the increase of age, especially for the elderly.
Source: Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research
More News: China Health | Chronic Leukemia | Chronic Myeloid Leukaemia | Drugs & Pharmacology | Genetics | Leukemia | Study